Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-07 00:58 | 2026-02-04 | HTFL | Heartflow, Inc. | Bain Capital Life Sciences Investors, LLC | 10% owner | Surgical & Medical Instruments & Apparatus | SALE | $28.05 | 2,000,000 | $56,100,000 | 10,448,158 | -16.1% |
| 2025-02-22 01:48 | 2025-02-19 | SLDB | Solid Biosciences Inc. | Bain Capital Life Sciences Investors, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $4.03 | 1,000,000 | $4,030,000 | 5,034,582 | +24.8% |
| 2025-01-14 00:34 | 2025-01-08 | OLMA | Olema Pharmaceuticals, Inc. | Bain Capital Life Sciences Investors, LLC | 10% owner | Pharmaceutical Preparations | BUY | $5.76 | 300,000 | $1,727,370 | 7,800,000 | +4.0% |
| 2024-02-15 01:26 | 2024-02-12 | KYTX | Kyverna Therapeutics, Inc. | Bain Capital Life Sciences Investors, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $22.00 | 450,000 | $9,900,000 | 3,163,868 | +16.6% |
| 2023-05-31 04:54 | 2023-05-25 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Investors, LLC | 10% owner | Pharmaceutical Preparations | BUY | $2.13 | 300,000 | $639,720 | 5,701,926 | +5.6% |
| 2021-12-11 04:33 | 2021-12-08 | XLO | Xilio Therapeutics, Inc. | Bain Capital Life Sciences Investors, LLC | 10% owner | Pharmaceutical Preparations | BUY | $9.66 | 42,469 | $410,161 | 2,805,413 | +1.5% |
| 2021-08-13 03:38 | 2021-08-10 | SWTX | N/A | Bain Capital Life Sciences Investors, LLC | 10% owner | Other | SALE | $70.25 | 1,000,000 | $70,250,000 | 4,831,307 | -17.1% |
| 2021-07-21 23:40 | 2021-07-19 | RPID | RAPID MICRO BIOSYSTEMS, INC. | Bain Capital Life Sciences Investors, LLC | 10% owner | Laboratory Analytical Instruments | BUY | $20.00 | 100,000 | $2,000,000 | 8,434,560 | +1.2% |
| 2021-03-12 00:30 | 2021-03-09 | SWTX | N/A | Bain Capital Life Sciences Investors, LLC | 10% owner | Other | SALE | $71.50 | 1,450,000 | $103,675,000 | 5,831,307 | -19.9% |
| 2020-10-28 00:07 | 2020-10-26 | APTX | N/A | Bain Capital Life Sciences Investors, LLC | 10% owner | Other | BUY | $3.00 | 3,333,333 | $9,999,999 | 8,891,758 | +60.0% |
| 2020-07-28 23:45 | 2020-07-28 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Investors, LLC | 10% owner | Pharmaceutical Preparations | BUY | $17.00 | 400,000 | $6,800,000 | 3,241,628 | +14.1% |
| 2020-02-07 00:26 | 2020-02-04 | ARQT | Arcutis Biotherapeutics Inc. | Bain Capital Life Sciences Investors, LLC | 10% owner | Pharmaceutical Preparations | BUY | $17.00 | 294,117 | $4,999,989 | 3,979,292 | +8.0% |
| 2019-11-22 00:26 | 2019-11-19 | DRNA | N/A | Bain Capital Life Sciences Investors, LLC | 10% owner | Other | SALE | $22.03 | 1,750,000 | $38,552,500 | 5,580,237 | -23.9% |
| 2019-09-20 02:05 | 2019-09-17 | SWTX | N/A | Bain Capital Life Sciences Investors, LLC | 10% owner | Other | BUY | $18.00 | 150,000 | $2,700,000 | 7,281,307 | +2.1% |
| 2019-05-31 23:15 | 2019-05-29 | DRNA | N/A | Bain Capital Life Sciences Investors, LLC | Director, 10% owner | Other | SALE | $12.50 | 1,600,000 | $20,000,000 | 7,330,237 | -17.9% |
| 2018-07-26 23:27 | 2018-07-24 | REPL | Replimune Group, Inc. | Bain Capital Life Sciences Investors, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $15.00 | 500,000 | $7,500,000 | 2,838,968 | +21.4% |
| 2017-12-20 00:52 | 2017-12-18 | DRNA | N/A | Bain Capital Life Sciences Investors, LLC | Director, 10% owner | Other | BUY | $7.00 | 285,000 | $1,995,000 | 285,000 | +100.0% |
| 2017-12-20 04:30 | 2017-12-15 | MRNS | N/A | Bain Capital Life Sciences Investors, LLC | 10% owner | Other | SALE | $7.88 | 1,272,547 | $10,024,744 | 3,977,453 | -24.2% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.